Predominant cytosolic localization of type II transforming growth factor β receptors in human breast carcinoma cells

Cancer Research

Volumn 57, Issue 5, 1997, Pages 970-977

  Koli, Katri M ^a,b   Arteaga, Carlos L ^a,b,c,d  

^a Department of Medicine ^*  (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; BREAST CARCINOMA; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; ISOTOPE LABELING; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; CELL COMPARTMENTATION; CELL MEMBRANE; CYTOSOL; DOXORUBICIN; DRUG RESISTANCE; FEMALE; GLYCOSYLATION; HUMANS; PHOSPHOPROTEINS; PHOSPHORYLATION; POINT MUTATION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0031018576     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Laiho, M., and Keski-Oja, J. Transforming growth factor-βs as regulators of cellular growth and phenotype. Crit. Rev. Oncog., 3: 1-26, 1992.
2. Alexandrow, M. G., and Moses, H. L. Transforming growth factor β and cell cycle regulation. Cancer Res., 55: 1452-1457, 1995.
3. Massugué, J. The transforming growth factor-β family. Annu. Rev. Cell Biol., 6: 597-641, 1990.
4. Miyazono, K., Hellman, U., Wernstedt, C., and Heldin, C-H. Latent high molecular weight complex of transforming growth factor-β1. Purification from human platelets and structural characterization. J. Biol. Chem., 263: 6407-6415, 1988.
5. Olofsson, A., Miyazono, K., Kanzaki, T., Colosetii, P., Engström, U., and Heldin, C-H. Transforming growth factor-β1, -β2, and -β3 secreted by a human glioblastoma cell line. Identification of small and large latent complexes. J. Biol. Chem., 267: 19482-19488, 1992.
6. Massagué, J., Attisano, L., and Wrana, J. L. The TGFβ family and its composite receptors. Trends Cell Biol., 4: 172-178, 1994.
7. Derynck, R. TGF-β-receptor-mediated signaling. Trends Biochem. Sci., 19: 548-553, 1994.
8. Yingling, J. M., Wang, X-F., and Bassing, C. H. Signaling by the transforming growth factor-β receptors, Biochem. Biophys. Acta, 1242: 115-136, 1995.
9. Wang. X-F., Lin, H. Y., Ng-Eaton, E., Downward, J., Lodish. H. F., and Weinberg, R. A. Expression cloning and characterization of the TGFβ type III receptor, Cell, 67: 797-805, 1991.
10. Franzén. P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C-H., and Miyazono, K. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell, 75: 681-692, 1993.
11. Lin, H. Y., Wang, X-F., Ng-Eaton, E., Weinberg, R. A., and Lodish, H. F. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell, 68: 775-785, 1992.
12. ten Dijke, P., Yamashita, H,. Ichijo, H., Franzén, P., Laiho, M., Miyazono, K., and Heldin, C-H. Characterization of type I receptors for transforming growth factor-β and activin. Science (Washington DC), 264: 101-104, 1994.
13. Wrana, J. L., Attisano, L., Cárcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X-F., and Massugué, J. TGF-β signals through a heteromeric protein kinase receptor complex. Cell, 71: 1003-1014, 1992.
14. Weis-Garcia, F., and Massagué, J. Complementation between kinase-defective and activation-defective TGF-β receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J., 15; 276-289, 1996.
15. Wrana, J. L., Attisano. L., Wiser, R., Ventura, F., and Massagué, J. Mechanism of activation of the TGF-β receptor, Nature (Lond.), 370: 341-347, 1994.
16. Chen, F., and Weinberg, R. A. Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor β receptor kinases. Proc. Natl. Acad. Sci. USA, 92: 1565-1569, 1995.
17. Chen, R-H., Ebner, R., und Derynck, R. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science (Washington DC), 260: 1335-1338, 1993.
18. Saitoh, M., Nishitoh, H., Amagasa, T., Miyazono, K., Takagi, M., and Ichijo, H. Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-β. J. Biol. Chem., 271: 2769-2775, 1996.
19. Wang, T., Donahoe, P. K., and Zervos, A. S. Specific interaction of type I receptors of the TGF-β family with the immunophilin FKBP-12. Science (Washington DC), 265: 674-676, 1994.
20. Kawabata, M., Chytil, A., Engel, M., Miyazono, K., and Moses, H. L. Identification of cellular proteins that hind the cytoplasmic region of the type I TGF-β receptor. Abstracts of the 9th International Conference on 2nd messengers and phosphoproteins, no. 590, 1995.
21. Chen, R-H., Miettinen, P. J., Maruoka, E. M., Choy, L., and Derynck, R. A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor. Nature (Lond.), 377: 548-552, 1995.
22. Liu, F., Hata, A., Baker, J. C., Doody, J., Cárcamo, J., Harland, R. M., and Massagué, J. A human Mad protein acting as a BMP-regulated transcriptonal activator. Nature (Lond.), 381: 620-623, 1996.
23. Massagué, J. TGFβ signaling: receptors, transducers, and Mad proteins. Cell, 85: 947-950, 1996.
24. Sun, L., Wu, G., Willson, J. K. V., Zborowska, E., Yang, J., Rajkarunanayake, I., Wang, J., Gentry, L. E., Wang, X-F., and Brattain, M. G. Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J. Biol. Chem., 268: 26449-26455, 1994.
25. Nørgaard, P., Damstrup, L., Rygaard, K., Spang-Thomsen, M., and Poulsen, H. S. Growth suppression by transforming growth factor-ø1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor. Br. J. Cancer, 69: 802-808, 1994.
26. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Willson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC). 268: 1336-1338, 1995.
27. Parsons, R., Myeroff, L. L., Liu, B., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. Microsutellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res., 55: 5548-5550, 1995.
28. Park, K., Kim, S-J., Bang, Y-J., Park, J-G., Kim, N. K., Roberts, A. B., and Sporn, M. B. Genetic changes in the transforming growth factor β (TGFβ) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGFβ. Proc. Natl. Acad. Sci. USA, 91: 8772-8776, 1994.
29. Garrigue-Antar, L., Muňoz-Antonia, T., Antonia, S. J., Gesmonde, J., Vellucci, V. F., and Reiss, M. Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res., 55: 3982-3987, 1995.
30. Kadin, M. E., Cavaille-Coll, M. W., Gertz, R., Massagué, J., Cheifetz, S., and George, D. Loss of receptors for transforming growth factor β in human T-cell malignancies. Proc. Natl. Acad. Sci. USA, 91: 6002-6006, 1994.
31. Nørgaard, P., Hougaard, S., Poulsen, H. S., and Spang-Thomsen. M. Transforming growth factor β and cancer. Cancer Treat. Rev., 21: 367-403, 1995.
32. Arteaga, C. L., Coffey, R. J., Dugger, T. C., McCutchen, C. M., Moses, H. L., and Lyons, R. M. Growth stimulation of human breast cancer cells with anti-transforming growth factor β antibodies: evidence for negative autocrine growth regulation by transforming growth factor β. Cell Growth & Differ., 1: 367-374, 1990.
33. Robinson, S. D., Silberstein, G. B., Roberts, A. B., Flanders, K. C., and Daniel, C. W. Regulated expression and growth inhibitory effects of transforming growth factor-β isoforms in mouse mammary gland development. Development (Camb.), 113: 867-878, 1991.
34. Daniel, C. W., Silberstein, G. B., Van Horn, K., Strickland, P., and Robinson, S. TGF/β1-induced growth inhibition of mouse mammary ductal growth: developmental specificity and characterization. Dev. Biol., 135: 20-30, 1989.
35. Brattain, M. G., Ko, Y., Banerji, S. S., Wu, G., and Willson, J. K. V. Defects of TGFβ receptor signaling in mammary cell tumorigenesis. J. Mammary Gland Bio. Neoplasia, in press. 1996.
36. Yamada, N., Kato, M., Yamashita, H., Nistér, M., Miyazono, K., Heldin, C-H., and Funa, K. Enhanced expression of transforming growth factor-β and its type-1 and type-II receptors in human glioblastoma. Int. J. Cancer, 62: 386-392, 1995.
37. Vickers, P. J., Dickson, R. B., Shoemaker, R., and Cowan, K. H. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent growth in viva. Mol. Endocrinol., 2: 886-892, 1988.
38. Sumbrook, J., Fritsch, E. F., and Maniatis, T. E. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
39. Arteaga, C. L., Tandon, A. K., Von Hoff, D. D., and Osborne, C. K. Transforming growth factor β: a potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res., 48: 3898-3904, 1988.
40. Arteaga, C. L., Carty-Dugger, T., Moses, H. L., Hurd, S. D., and Pietenpol, J. A. Transforming growth factor β1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice. Cell Growth & Differ., 4: 193-201, 1993.
41. Kalkhoven, E., Roelen, B. A. J., de Winter, J. P., Mummery, C. L., van den Eijnden-van Raaij, A. J. M., van der Saag, P. T., and van der Burg, B. Resistance to transforming growth factor β and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth & Differ., 6: 1151-1161, 1995.
42. Hirai, R., and Fujita, T. A human transforming growth factor-β type II receptor that contains an insertion in the extracellular domain. Exp. Cell Res., 223: 135-141, 1996.
43. Schindler, M., Grabski, S., Hoff, E., and Simon, S. M. Defective pH regulation of acidic compartments in human breast cancer cells (MCF-7) is normalized in Adriamycin-resistant cells (MCF-7adr). Biochemistry, 35: 2811-2817, 1996.
44. Fornari, F. A., Jr., Jarvis, W. D., Grant, S., Orr, M. S., Randolph, J. K., White, F. K. H., Mumaw, V. R., Lovings, E. T., Freeman, R. H., and Gewirtz, D. A. Induction of differentiation and growth arrest associated with nascent (nonoligosomal) DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells after continuous exposure to sublethal concentrations of doxyrubicin. Cell Growth & Differ., 5: 723-733, 1994.
45. Roy, S. K., and Kole, A. R. Transforming growth factor-β receptor type II expression in the hamster ovary: cellular site(s). biochemical properties, and hormonal regulation. Endocrinology, 136: 4610-4620, 1995.
46. ten Dijke, P., Yamashita, H., Ichijo, H., Franzén, P., Laiho, M., Miyazono, K., and Heldin, C-H. Characterization of type I receptors for transforming growth factor-β and activin. Science (Washington DC), 264: 101-104, 1994.
47. Capocasale, R. J., Lamb, R. J., Vonderheid, E. C., Fox, F. E., Rook, A. H., Nowell, P. C., and Moore, J. S. Reduced surface expression of transforming growth factor β receptor type II in mitogen-activated T cells from Sézary patients. Proc. Natl. Acad. Sci. USA, 92: 5501-5505, 1995.